Gene manipulation to enhance MIBG-targeted radionuclide therapy

Nuclear Medicine and Biology

Volumn 32, Issue 7, 2005, Pages 749-753

  Mairs, Robert J ^a   Fullerton, Natasha E ^a,b   Cosimo, Emilio ^a   Boyd, Marie ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Gene therapy; MIBG; Noradrenaline transporter; Targeted radiotherapy

Indexed keywords

IODINE 131;

ARTICLE; BINDING SITE; BLADDER CARCINOMA; CANCER THERAPY; DRUG UPTAKE; GENE CONTROL; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; GLIOMA; HUMAN; NEUROBLASTOMA; NONHUMAN; RADIATION DOSE; TUMOR CELL;

3-IODOBENZYLGUANIDINE; ANIMALS; DRUG DELIVERY SYSTEMS; GENE TARGETING; GENE THERAPY; HUMANS; NEUROBLASTOMA; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RADIOPHARMACEUTICALS; RADIOTHERAPY;

EID: 27144507056     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.03.011     Document Type: Article

References (54)

1. M.S. Kaminski, A.D. Zelenetz, O.W. Press, M. Saleh, J. Leonard, and L. Fehrenbacher Pivotal study of iodine I 131 tositumomab for chemotherapy- refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas J Clin Oncol 19 2001 3918 3928
2. K.F. Koral, Y. Dewaraja, J. Li, Q. Lin, D.D. Regan, and K.R. Zasadny Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients J Nucl Med 44 2003 457 464
3. T. Pacholczyk, R.D. Blakely, and S.G. Amara Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter Nature 350 1991 350 354
4. G. Dai, O. Levy, and N. Carrasco Cloning and characterization of the thyroid iodide transporter Nature 379 1996 458 460
5. P.A. Smanik, Q. Liu, T.L. Furminger, K. Ryu, S. Xing, and E.L. Mazzaferri Biochem Biophys Res Commun 226 1996 339 345
6. R.B. Mandell, L.Z. Mandell, and C.J. Link Jr Radioisotope concentrator gene therapy using the sodium/iodide symporter gene Hum Gene Ther 59 1999 661 668
7. A. Boland, M. Ricard, P. Opolon, J.M. Bidart, P. Yeh, and S. Filetti Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy Cancer Res 60 2000 3484 3492
8. S. Carlin, S.H. Cunningham, M. Boyd, A. McCluskey, and R.J. Mairs Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both 2 and 3 dimensional models Cancer Gene Ther 7 2000 1529 1536
9. E. Mitrofanova, R. Unfer, N. Vahanian, W. Daniels, E. Roberson, and T. Seregina Rat sodium iodide symporter for radioiodide therapy of cancer Clin Cancer Res 10 2004 6969 6976
10. A.W. Gaut, G. Niu, K.J. Krager, M.M. Graham, D.K. Trask, and F.E. Domann Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS) Head Neck 26 2004 265 271
11. H. Kakinuma, E.R. Bergert, C. Spitzweg, J.C. Cheville, M.M. Lieber, and J.C. Morris Probasin promoter (ARR(2)YB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer Cancer Res 63 2003 7840 7844
12. L.S. Zuckier, O. Dohan, Y. Li, C.J. Chang, N. Carrasco, and E. Dadachova Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo J Nucl Med 45 2004 500 507
13. X.Q. Lin, K.Y. Ryu, and S.M. Jhiang Cloning of the 5′-flanking region of mouse sodium/iodide symporter and identification of a thyroid-specific and TSH-responsive enhancer Thyroid 14 2004 19 27
14. C. Spitzweg, I.V. Scholz, E.R. Bergert, D.J. Tindall, C.Y.F. Young, and B. Goke Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells Endocrinology 144 2003 3423 3432
15. N. Fortunati, M.G. Catalano, K. Arena, E. Brignardello, A. Piovesan, and G. Boccuzzi Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells J Clin Endocrinol Metab 89 2004 1006 1009
16. M. Huang, R.K. Batra, T. Kogai, Y.Q. Lin, J.M. Hershman, and A. Lichtenstein Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer Cancer Gene Ther 8 2001 612 618
17. A. Boland, C. Magnon, S. Filetti, J.M. Bidart, M. Schlumberger, and P. Yeh Transposition of the thyroid iodide uptake and organification system in non-thyroid tumour cells by adenoviral vector-mediated gene transfer Thyroid 12 2002 19 26
18. 131I]iodobenzylguanidine J Nucl Med 21 1980 349 353
19. S. Jacques Jr, M.C. Tobes, J.C. Sisson, J.A. Baker, and D.M. Wieland Comparison of the sodium dependence of uptake of meta-iodo-benzylguanidine and norepinephrine into cultured bovine adrenomedullary cells Mol Pharmacol 26 1984 539 546
20. A. Garaventa, P. Guerra, A. Arrighini, L. Bertolazzi, M. Bestagno, and B. De Bernardi Treatment of advanced neuroblastoma with I-131 meta- iodobenzylguanide Cancer 67 1991 922 928
21. P.A. Voute, C.A. Hoefnagel, J. de Kraker, R. Valdes Olmos, D.J. Bakker, and A.J. van de Kleij Results of treatment with 131 I-meta-iodobenzylguanidine in patients with neuroblastoma. Future prospects of zetotherapy A.E. Evans G.J. D'Angio A.G. Knudson R.C. Seeger Advances in neuroblastoma research 3rd ed. 1991 Wiley-Liss New York 439 445
22. L.S. Lashford, I.J. Lewis, S.L. Fielding, M.A. Flower, S. Meller, and J.T. Kemshead Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation J Clin Oncol 10 1992 1889 1896
23. M.N. Gaze, and T.E. Wheldon Radiolabelled mIBG in the treatment of neuroblastoma Eur J Cancer 32 1996 93 96
24. R.J. Mairs, M.N. Gaze, and A. Barrett The uptake and retention of meta-iodobenzyl guanidine by the neuroblastoma cell line NB1-G Br J Cancer 64 1991 293 295
25. R.J. Mairs, S.H. Cunningham, J. Russell, A. Armour, J. Owens, and K. McKellar No-carrier-added 131I-mIBG: evaluation of a novel preparation of a therapeutic radiopharmaceutical J Nucl Med 36 1995 1088 1095
26. 131I-meta-iodo-benzyl guanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction Br J Cancer 70 1994 97 101
27. 131I]meta-iodobenzylguanidine by neuroblastoma tumours Clin Cancer Res 9 2003 3338 3344
28. B. Lingen, M. Bruss, and H. Bonisch Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter FEBS Lett 342 1994 235 238
29. 131I]meta-iodobenzylguanidine GeneTher 6 1999 1147 1152
30. J.L. Humm Dosimetric aspects of radiolabelled antibodies for tumour therapy J Nucl Med 27 1986 1490 1497
31. T.E. Wheldon Radiation physics and genetic targeting: new directions for radiotherapy Phys Med Biol 45 2000 R77 R95
32. 131I]meta-iodobenzyl guanidine, for the treatment of tumours transfected with the noradrenaline transporter gene Lett Drug Des Disc 1 2004 50 57
33. N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, and P.L. Ho Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
34. D. Broccoli, J.W. Young, and T. De Lange Telomerase activity in normal and malignant hematopoietic cells Proc Natl Acad Sci U S A 92 1995 9082 9086
35. C. Harle-Bachor, and P. Boukamp Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes Proc Natl Acad Sci U S A 93 1996 6476 6481
36. H. Tahara, W. Yasui, E. Tahara, J. Fujimoto, K. Ito, and K. Tamai Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections Oncogene 18 1999 1561 1567
37. S.L. Weinrich, R. Pruzan, L. Ma, M. Ouellette, V.M. Tesmer, and E.E. Holt Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT Nat Genet 17 1997 498 502
38. 131I]MIBG and clonogenic cell kill Oncogene 20 2001 7804 7808
39. M.R. Zalutsky, and G. Vaidyanathan Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy Curr Pharm Des 6 2000 1433 1455
40. M. Boyd, R.J. Mairs, W.N. Keith, S.C. Ross, P. Welsh, and G. Akabani An efficient targeted radiotherapy/ gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects J Gene Med 6 2004 937 947
41. D.J. Bushsbaum, and D.T. Curiel Gene therapy for the treatment of cancer Cancer Biother Radiopharm 16 2001 275 288
42. D.E. Hallahan, H.J. Mauceri, L.P. Seung, E.J. Dunphy, J.D. Wayne, and N.N. Hanna Spatial and temporal control of gene therapy using ionising radiation Nat Med 8 1995 786 791
43. T. Joki, M. Nakamura, and T. Ohno Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir Hum Gene Ther 6 1995 1507 1513
44. M.-J. Staba, H.J. Mauceri, D.W. Kufe, D.E. Hallahan, and R.R. Weichselbaum Adenoviral TNF-α gene therapy and radiation damage to tumour vasculature in human malignant glioma xenografts Gene Ther 5 1998 293 300
45. B. Marples, S.D. Scott, J.H. Hendry, M.J. Embleton, L.S. Lashford, and G.P. Margison Development of synthetic promoters for radiation mediated gene therapy Gene Ther 7 2000 511 517
46. S.D. Scott, B. Marples, J.H. Hendry, L.S. Lashford, M.J. Embleton, and R.D. Hunter A radiation controlled molecular switch for use in gene therapy of cancer Gene Ther 7 2000 1121 1125
47. Y. Manome, T. Kunieda, P.Y. Wen, D.W. Kufe, and T. Ohno Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the EGR-1 promoter: activation by ionising radiation or uptake of radioactive iododeoxyuridine Hum Gene Ther 9 1998 1409 1417
48. J. Worthington, T. Robson, M. Murray, M. O'Rourke, G. Keilty, and D.G. Hirst Modification of vascular tone using iNOS under the control of a radiation-inducible promoter Gene Ther 7 2000 1126 1131
49. J. Worthington, T. Robson, M. O'Keeffe, and D.G. Hirst Tumour cell radiosensitisation using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy Gene Ther 9 2002 263 269
50. V. Papanastassiou, R. Rampling, M. Fraser, R. Petty, D. Hadley, and J. Nicoll The potential for efficacy of the modified(ICP34.5) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study Gene Ther 9 2002 398 406
51. M. Boyd, H.S. Spenning, and R.J. Mairs Radiation-mediated gene therapy: rays of hope for the new millenium? Curr Gene Ther 3 2003 319 339
52. CCluskey Application of targeted radiotherapy/gene therapy to bladder cancer cell lines Eur Urol 47 2005 250 256
53. N. Melissourgos, N.G. Kastrinakis, I. Davilas, P. Foukas, A. Farmakis, and M. Lykourinas Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker Urology 62 2003 362 367
54. M. Mueller Telomerase: its clinical relevance in the diagnosis of bladder cancer Oncogene 21 4 2002 650 655